📊 Liquidity Ratios

• 
  
  Current Ratio = Current Assets ÷ Current Liabilities
  • Current Assets: RMB  376m
  • Current Liabilities: RMB  248m
  • Current Ratio = 1.51
    &rarr Above 1, meaning short-term assets cover liabilities, but the margin is shrinking compared to prior years (cash fell sharply).
• 
  
  Quick Ratio = (Current Assets &ndash Inventories) ÷ Current Liabilities
  • Inventories: RMB  44m
  • Quick Assets: RMB  332m
  • Quick Ratio = 1.34
    &rarr Still liquid, but declining cash reserves are a concern.

⚖ ️ Leverage Ratios

• 
  
  Debt-to-Equity = Total Liabilities ÷ Equity
  • Liabilities: RMB  248m
  • Equity: RMB  451m
  • Debt-to-Equity = 0.55
    &rarr Moderate leverage, but equity erosion from losses is weakening the buffer.
• 
  
  Interest Coverage = EBIT ÷ Finance Costs
  • EBIT: &ndash RMB  159m (loss)
  • Finance Costs: RMB  7.6m
  • Coverage = Negative
    &rarr Company cannot cover interest from operations, relying on cash reserves.

📉 Profitability Ratios

• 
  
  Gross Margin = Gross Profit ÷ Revenue
  • Gross Loss: &ndash RMB  107.5m
  • Revenue: RMB  107.5m
  • Gross Margin = &ndash 100%
    &rarr Selling prices remain below production costs.
• 
  
  Net Margin = Net Profit ÷ Revenue
  • Net Loss: &ndash RMB  166.9m
  • Revenue: RMB  107.5m
  • Net Margin = &ndash 155%
    &rarr Deeply negative, showing structural unprofitability.
• 
  
  ROE = Net Profit ÷ Equity
  • &ndash RMB  166.9m ÷ RMB  451m = &ndash 37%
    &rarr Heavy destruction of shareholder value.

🔄 Efficiency Ratios

• 
  
  Asset Turnover = Revenue ÷ Total Assets
  • RMB  107.5m ÷ RMB  699m = 0.15
    &rarr Very low efficiency assets are underutilized.
• 
  
  Cash Conversion Cycle:
  • Inventories: RMB  44m, Receivables: RMB  48m, Payables: RMB  104m.
  • Working capital cycle is stretched, but payables partly offset receivables/inventory.

📌 Key Takeaway

• Liquidity is adequate but deteriorating (cash burn is the main risk).
• Leverage is moderate, but interest coverage is negative.
• Profitability is deeply negative, with gross margin at &ndash 100%.
• Efficiency is poor, with low asset turnover.

📊 Financial Performance Overview

• Revenue: RMB  107.5m (&uarr 113% YoY)
  • Driven by trial production at the new 100,000-ton methylamine plant.
  • Methylamine sales contributed RMB  98.9m (vs RMB  39.2m in FY2024).
• Gross Loss: RMB  107.5m (vs RMB  83.2m in FY2024).
  • Selling prices remained below production costs due to oversupply and weak demand in China.
• Net Loss: RMB  166.9m (vs RMB  147.9m in FY2024).
  • Loss per share widened to 8.40 RMB cents (vs 7.44).
• Other Income: RMB  6.5m (&darr 38% YoY), mainly lower interest income.
• Expenses:
  • Admin costs fell 12% to RMB  24.3m.
  • Finance costs rose 25% to RMB  7.6m due to new plant borrowings.
  • Impairment losses on PPE: RMB  11.4m (vs RMB  4.3m).

📉 Balance Sheet Highlights

• Total Assets: RMB  699m (&darr 33% YoY).
• Cash & Equivalents: RMB  198m (&darr 62% YoY).
• Equity: RMB  451m (&darr 27% YoY).
• Bank Borrowings: RMB  125m (&darr 46% YoY).
• Net Asset Value per Share: RMB  22.68 cents (vs 31.08 cents).

💡 Cash Flow Analysis

• Operating Cash Flow: &ndash RMB  124m (vs &ndash RMB  81m).
• Investing Cash Flow: &ndash RMB  25m (mainly PPE payments).
• Financing Cash Flow: &ndash RMB  126m (repayment of borrowings and bills).
• Net Cash Outflow: RMB  275m, leaving cash at RMB  185m.

🏭 Industry & Strategic Context

• Industry Conditions:
  • China&rsquo s chemical sector faces oversupply, weak domestic demand, and renewed US tariffs.
  • Prices for DMF and methylamine remain depressed.
• Jiutian&rsquo s Strategy:
  • Trial production at new methylamine plant to improve efficiency.
  • Cost optimization and reduced admin/distribution expenses.
  • No dividend declared to preserve liquidity.

⚠ ️ Risks & Considerations

• Liquidity Risk: Sharp cash decline and continued operating losses raise sustainability concerns.
• Market Risk: Oversupply and weak demand may keep selling prices below cost.
• Asset Impairments: Continued write-downs of PPE signal underutilization.
• JV Exposure: Losses from Anyang Jiulong Chemical (49% stake) fully impaired.

📌 Fundamental Takeaway

原 地 奔 跑  😂 😂 😂 😂 😂 
快 要 跑 了 ,不 要 心 急